Contrast media injectors market to be valued $2.3b by 2029

Rising healthcare expenditures in China and India bring forth opportunities for market growth.

The global market for contrast media injectors is anticipated to reach $2.3b by 2029 at a compound annual growth rate (CAGR) of 8%, according to a MarketsandMarkets™ analysis.

The report mentioned that the market is driven by the rising incidence of cancer and cardiovascular diseases, particularly amongst the ageing population.

Moreover, the market is poised to witness injector technology advancements for enhanced diagnostic accuracy and early detection.

An increase in disposable incomes and expanding healthcare access in emerging markets are also expected to contribute to further growth.

“Opportunities arise from rising healthcare expenditure in countries like China, India, Brazil, and Mexico, driven by government initiatives and increasing demand for advanced healthcare services,” the report said.

Meanwhile, MarketsandMarkets™ revealed that by end-user, the hospitals segment attributed a major market share in 2023 due to a growing focus on healthcare research and increasing funding opportunities from public and private organisations.

By application, the radiology segment held a significant market share in 2023 and was driven by a rising prevalence of cancer cases and increasing regulatory approvals of contrast agents.